CARDIOVASCULAR DISEASE RISK DURING MENOPAUSE: PATHOPHYSIOLOGY, CLINICAL SIGNIFICANCE AND PREVENTION
Keywords:
menopause, cardiovascular disease, estrogen deficiencyAbstract
Menopause represents a critical transition in a woman’s life, characterized by the cessation of ovarian function and a decline in estrogen levels. This hormonal shift is strongly associated with an increased risk of cardiovascular diseases (CVD), which are the leading cause of mortality among women globally. The loss of estrogen’s protective effects leads to metabolic changes, endothelial dysfunction, dyslipidemia, and increased arterial stiffness. This article explores the mechanisms underlying increased cardiovascular risk during menopause, evaluates epidemiological trends, and discusses diagnostic and preventive strategies. The findings emphasize the need for early risk assessment and targeted interventions in menopausal women.
References
1. World Health Organization (2021). Cardiovascular disease in women report.
2. Manson JE et al. (2013). Menopause and cardiovascular disease. New England Journal of Medicine.
3. Rossouw JE et al. (2002). Risks and benefits of HRT. JAMA.
4. North American Menopause Society (2020). Guidelines.
5. Mosca L et al. (2011). Cardiovascular prevention in women. Circulation.
6. El Khoudary SR et al. (2020). Menopause and CVD. Lancet Diabetes & Endocrinology
7. Mendelsohn ME, Karas RH. (2005). Estrogen effects. NEJM
8. Writing Group WHI (2002). Hormone therapy study
9. Yusuf S et al. (2001). Global risk factors. Lancet
10. Santen RJ et al. (2010). Hormone therapy review
